Cite

MLA Citation

    Shiri Guy‐Alfandary et al.. “Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID‐19 Patients: A Perspective from an Israeli Cross‐Sector Collaboration.” Clinical pharmacology & therapeutics, vol. 112, no. 6, 2022, pp. 1156–1158. http://access.bl.uk/ark:/81055/vdc_100170099628.0x000061
  
Back to record